Skip to main content
. 2021 Aug 25;23(1):16–28. doi: 10.1111/hiv.13157

FIGURE 2.

FIGURE 2

Consort diagram: Tambua Mapema Plus Trial profile. Five (4.2%) and twelve (3.7%) participants in the observation and intervention phases, respectively, provided more than one reason when they refused research participation